Healthcare & Life Sciences
Target Company
Theragenics Corporation (NYSE: TGX)
Juniper Acquisition Corporation, an affiliate of Juniper Investment Company, LLC.

Client Description:

Theragenics has two divisions. Its Brachytherapy business is a global leader in the production of implantable devices and related disposable products that support low-dose radiation therapy for prostate cancer. Its Surgical Products business produces a broad set of devices and consumables that are used in wound closure, vascular access, and specialty needle applications.